Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from IQV

How Is Charles River Laboratories’ Stock Performance Compared to Other Health Care Stocks?

Despite underperforming its industry peers over the past year, analysts remain highly bullish on Charles River Laboratories' long-term prospects.

Barchart

Is IQVIA Holdings Stock Outperforming the Dow?

IQVIA Holdings has outperformed the Dow over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart

Are Wall Street Analysts Predicting IQVIA Holdings Stock Will Climb or Sink?

While IQVIA Holdings has lagged behind the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

IQVIA Holdings Earnings Preview: What to Expect

IQVIA Holdings is all set to post its first quarter earnings shorlty and analysts expect a single-digit boost in its profitability.

Barchart

Is IQVIA Holdings Stock Underperforming the Nasdaq?

IQVIA Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

Is Wall Street Bullish or Bearish on IQVIA Holdings Stock?

IQVIA Holdings has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors

Healthcare stocks rebounded in 2025. These three healthcare growth stocks offer exposure to innovation beyond traditional biotech risk

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

What You Need To Know Ahead of IQVIA’s Earnings Release

Here’s what you need to know before life sciences analytics company IQVIA reports its Q4 earnings.

Barchart

Is IQVIA Holdings Stock Outperforming the S&P 500?

IQVIA Holdings has significantly outperformed the broader S&P 500 Index in recent months, and analysts remain strongly bullish on the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on IQVIA Holdings Stock?

IQVIA Holdings has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

What to Expect From IQVIA Holdings’ Next Quarterly Earnings Report

IQVIA Holdings is gearing up to release its third-quarter earnings later this month, and analysts project a steady single-digit increase in profitability.

Barchart

Revvity Stock: Is RVTY Underperforming the Healthcare Sector?

Despite Revvity’s weak performance relative to the healthcare sector, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

How Is IQVIA Holdings' Stock Performance Compared to Other Health Tech Stocks?

Although IQVIA has lagged behind its health tech peers over the past year, Wall Street analysts maintain a highly confident outlook on the stock’s future performance.

Barchart

D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mixed, with the Nasdaq Composite falling around 100 points on Tuesday.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

What to Expect From IQVIA Holdings' Q2 2025 Earnings Report

IQVIA Holdings is all geared up to announce its second-quarter earnings towards the end of this month, and analysts anticipate a single-digit bottom-line growth.

Barchart

IQVIA Stock: Is Wall Street Bullish or Bearish?

Although IQVIA has lagged behind the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Here's What to Expect from IQVIA Holdings' Next Earnings Report

IQVIA Holdings is gearing up to announce its Q1 results in the next month, and analysts expect a single-digit growth in earnings.

Barchart

Is IQVIA Holdings Stock Underperforming the Dow?

IQVIA Holdings has significantly underperformed the Dow over the past year, yet analysts remain strongly bullish on the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

IQVIA Holdings Stock: Analyst Estimates & Ratings

IQVIA Holdings has trailed the broader market over the past year, but analysts on Wall Street maintain a very bright outlook on the stock’s growth prospects.

Barchart

Nvidia Could Power Up This Under-the-Radar Healthcare Stock

A partnership with Nvidia is bound to yield fruitful results for this little-known company.

Barchart

Earnings Preview: What to Expect From IQVIA Holdings' Report

IQVIA Holdings will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

Barchart

This Little-Known Healthcare Company Has a ‘Strong Buy’ Rating and a New Nvidia Partnership

The company will leverage Nvidia’s prowess in AI to build proprietary models.

Barchart

Is IQVIA Holdings Stock Underperforming the Nasdaq?

IQVIA Holdings has considerably underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like IQVIA Holdings Stock?

IQVIA Holdings has underperformed the broader market over the past year, but Wall Street analysts are bullish about the stock’s prospects.

Barchart

IQVIA Holdings' Quarterly Earnings Preview: What You Need to Know

With IQVIA Holdings gearing up to release its third-quarter earnings later this month, analysts project a double-digit surge in earnings.

1 2

Organisations

Charles River Laboratories

17 stories

IQVIA Holdings

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Health Care

3,278 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.